Does CareFirst BlueCross BlueShield Cover Ozempic?
The verdict
Conditional on most plans
CareFirst BlueCross BlueShield covers Ozempic for type 2 diabetes with prior authorization — it does not cover Ozempic for off-label weight-loss use. CareFirst's ACA Exchange plans explicitly exclude GLP-1 weight-loss drugs, while Ozempic for T2D is consistently covered with standard PA across commercial, Medicare Advantage, and Medicaid lines. FEHB enrollees with a T2D diagnosis are treated as commercial patients for the purposes of the NovoCare savings card.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with CareFirst BlueCross BlueShield using your member ID.
Key facts
Ozempic is FDA-approved for type 2 diabetes glycemic control and cardiovascular risk reduction in T2D patients — not for weight loss.
FDA drug labeling (semaglutide injection)
CareFirst ACA Exchange plans explicitly exclude weight-loss GLP-1 drug coverage; Ozempic T2D coverage is unaffected by this exclusion.
CareFirst BlueCross BlueShield, ACA Exchange drug benefit documentation
FEHB enrollees are treated as commercial insurance for manufacturer savings cards; the NovoCare $25 Ozempic card may apply to eligible T2D patients.
NovoCare Ozempic Savings Card program terms
Medicare vs. commercial coverage
Whether CareFirst BlueCross BlueShield covers Ozempic depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Advantage (CareFirst Medicare Advantage): Ozempic is covered for type 2 diabetes with prior authorization. PA requires a documented T2D diagnosis and evidence of metformin step-therapy or a documented contraindication. The 2026 Part D out-of-pocket cap of $2,100 limits annual beneficiary spending on covered drugs. Medicare Advantage enrollees cannot use the NovoCare savings card — federal anti-kickback rules exclude Medicare beneficiaries. The IRA Maximum Fair Price for semaglutide (Ozempic/Rybelsus/Wegovy) is $274 per 30-day supply, effective January 1, 2027. Ozempic is not covered for weight loss under Medicare Advantage.
Commercial / Employer
Group & marketplace plans
Commercial/Employer (including FEHB): Ozempic is covered for type 2 diabetes with prior authorization. Tier placement on large-group commercial plans is not publicly confirmed — Tier 2 or Tier 4 depending on plan design per the research; verify on CareFirst's drug-lookup tool. FEHB enrollees on CareFirst are treated as commercial insurance enrollees, not government program beneficiaries — they may be eligible for the NovoCare Ozempic Savings Card ($25 per fill, max $150 per 28-day supply) — verify at NovoCare.com. Not covered for off-label weight loss. ACA/Individual: covered for T2D with PA; CareFirst ACA Exchange plans explicitly exclude weight-loss GLP-1 coverage per documented CareFirst policy. This weight-loss exclusion does not affect Ozempic T2D coverage. Medicaid (DC Medicaid, Maryland Medicaid): covered for type 2 diabetes with PA and nominal Medicaid cost-share. Not covered for off-label weight loss. Medicaid enrollees cannot use the NovoCare savings card.
The 3 boxes you must tick to get approved
Commercial plans that will consider Ozempic require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 3 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Ozempic actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
~$1,028/month (Novo Nordisk published pricing, ~$1,027.51 for the 0.25/0.5 mg pen). NovoCare self-pay: ~$199/month intro price (first two fills through December 31, 2026), then ~$349/month (0.25/0.5/1 mg) or ~$499/month (2 mg).
List price with no coverage — before any manufacturer savings card.
With coverage
Commercial/FEHB: plan-specific cost-share (Tier 2 or Tier 4 on large-group plans, per research) — verify on CareFirst drug-lookup tool. Medicare Advantage: cost-share depends on plan tier; $2,100 Part D OOP cap applies in 2026; IRA Maximum Fair Price of $274/30-day for semaglutide takes effect January 1, 2027. Medicaid (DC/MD): nominal cost-share.
Typical monthly copay once prior authorization is approved.
Bridge program
NovoCare Ozempic Savings Card: commercially insured T2D patients — including FEHB enrollees — may pay as little as $25 per fill (max $150 per 28-day supply). Not available to Medicare, Medicaid, VA, DoD, or TRICARE beneficiaries. FEHB is treated as commercial insurance; verify eligibility at NovoCare.com.
Reduced copay through the assistance program, where eligible.
All figures are estimates — verify exact cost-share with CareFirst member services or on your plan's drug-lookup tool. Tier placement and cost-share vary by specific plan design and line of business.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Look up Ozempic on CareFirst's drug-lookup tool
Log in to your CareFirst member account at carefirst.com and use the formulary or drug-lookup tool to confirm Ozempic's tier and any prior-authorization or step-therapy requirements on your specific plan. Tier and PA requirements vary by plan type (commercial, FEHB, Medicare Advantage, ACA, Medicaid).
- 2
Have your prescriber initiate the prior-authorization request
Ask your provider to submit a PA request to CareFirst documenting: a T2D diagnosis (ICD-10 E11.x), evidence of metformin use or a documented contraindication. The clinical indication must be type 2 diabetes — not weight management. FEHB enrollees should confirm which FEHB plan applies and its specific formulary.
- 3
Check FEHB savings-card eligibility and 2027 IRA pricing
If you are on a CareFirst FEHB plan with a T2D diagnosis, ask your pharmacist about the NovoCare $25 savings card — FEHB is treated as commercial insurance. If you are on Medicare Advantage, note the IRA Maximum Fair Price of $274/30-day for semaglutide effective January 1, 2027. Call CareFirst member services for a personalized cost estimate.
Options if CareFirst BlueCross BlueShield won't cover Ozempic
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Rybelsus (oral semaglutide)
Oral semaglutide tablet for type 2 diabetes. Also covered for T2D with PA on most CareFirst formularies. Subject to the IRA Maximum Fair Price of $274/30-day effective January 1, 2027 for Medicare patients. Verify tier on CareFirst drug-lookup.
Jardiance (empagliflozin)
SGLT-2 inhibitor commonly used as step-therapy before GLP-1 approval. Often at a lower cost-share tier than Ozempic on commercial formularies.
Metformin (generic)
First-line oral diabetes medication universally covered at low cost on commercial and Medicaid formularies. Required as step therapy before Ozempic PA approval in most plans.
Compounded semaglutide (weight-loss seekers only)
For DC/MD/VA patients seeking semaglutide for weight management who are denied by CareFirst — including those on ACA plans with the explicit GLP-1 weight-loss exclusion — compounded semaglutide from $49/mo is available at getcurex.com/cl/glp without insurance. See the Curex offer section below for full disclaimers.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
No. CareFirst does not cover Ozempic for weight loss under any plan. Ozempic holds FDA approval for type 2 diabetes and cardiovascular risk reduction in T2D patients — not for chronic weight management. CareFirst's ACA Exchange plans explicitly exclude weight-loss GLP-1 drugs, and that exclusion is consistent with the universal rule: no insurer covers Ozempic for off-label weight loss. T2D patients are covered; weight-loss seekers are not.
Yes, CareFirst covers Ozempic for type 2 diabetes with prior authorization across commercial, FEHB, ACA, Medicare Advantage, and Medicaid (DC/MD) lines. Your prescriber must document a T2D diagnosis and evidence of metformin step-therapy or a contraindication. Formulary tier and cost-share vary by plan — verify on CareFirst's drug-lookup tool. FEHB enrollees should check their specific FEHB plan formulary, as individual FEHB plans may have their own drug benefit structures.
Yes, generally. FEHB (Federal Employees Health Benefits) plans are treated as commercial insurance, not government programs, for the purposes of manufacturer savings cards. CareFirst FEHB enrollees with a T2D diagnosis may be eligible for the NovoCare Ozempic Savings Card ($25 per fill, max $150 per 28-day supply) — verify eligibility at NovoCare.com. This is a meaningful difference from Medicare and Medicaid enrollees, who are categorically excluded from manufacturer copay cards.
No. CareFirst's documented exclusion of weight-loss GLP-1 drugs on ACA Exchange plans applies to on-label weight-management medications (like Wegovy). Ozempic prescribed for type 2 diabetes is covered on ACA plans through the standard T2D PA pathway. The two indications are entirely separate: T2D is a covered medical condition regardless of the weight-loss drug exclusion. Patients seeking weight-loss coverage through an Ozempic prescription on an ACA plan will be denied; patients prescribed Ozempic for legitimate T2D management will be approved with PA.
Under CareFirst commercial plans, cost-share depends on the plan's tier placement for Ozempic — Tier 2 or Tier 4 on large-group plans per available data; verify on CareFirst's drug-lookup tool. FEHB commercial enrollees may pay as little as $25/fill with the NovoCare savings card. Under Medicare Advantage, the 2026 Part D OOP cap limits total annual spending to $2,100. The IRA Maximum Fair Price for semaglutide drops to $274/30-day for Medicare patients from January 1, 2027. Contact CareFirst member services for a personalized estimate.
Related Articles
Does CareFirst BlueCross BlueShield Cover Mounjaro? 2026 | Curex
CareFirst BlueCross BlueShield (MD/DC/VA) covers Mounjaro for type 2 diabetes with prior authorization — not weight loss. Medicaid state-dependent.
Read moreDoes CareFirst BlueCross BlueShield Cover Prolia? 2026 | Curex
CareFirst BCBS (MD/DC/N.VA) covers Prolia under the medical benefit with PA. Jubbonti preferred at several BCBS licensees now. Verify at carefirst.com.
Read moreDoes Aetna Cover Prolia? CVS Caremark Medical Benefit | Curex
Aetna covers Prolia under the medical benefit with PA — a q6-month clinic injection, not Part D. Jubbonti biosimilar now preferred on CVS Caremark.
Read moreDoes Aetna Cover Contrave? 2026 CVS Caremark Guide | Curex
Aetna (CVS Caremark) often excludes Contrave under AOM carve-outs. Where covered, CVS BMI prior auth applies. Medicare bars it by law. CurAccess ~$99/mo.
Read moreDoes Aetna Cover Forteo? 2026 Coverage Guide
Aetna (CVS) often excludes brand Forteo in favor of generic teriparatide or Bonsity. Teriparatide is covered with PA and bisphosphonate step therapy. 2026.
Read moreDoes CareFirst BCBS Cover Wegovy? 2026 Guide | Curex
CareFirst BCBS covers Wegovy on large-group plans (Tier 2/4, PA required) but excludes it on ACA Exchange plans. 2026 criteria explained.
Read moreInsurance won't cover Ozempic for weight loss — here's a path that doesn't need it
CareFirst does not cover Ozempic for off-label weight loss — and CareFirst ACA Exchange plans explicitly exclude GLP-1 weight-loss drugs. For DC, Maryland, and Virginia patients seeking semaglutide for weight management without insurance coverage, Curex offers compounded semaglutide starting at $49/mo with no prior authorization needed. Compounded tirzepatide is also available from $149/mo. Compounded semaglutide is not the same medication as Ozempic or Wegovy. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Ozempic and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with CareFirst BlueCross BlueShield before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Ozempic and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.